Cyclin E and c-Myc promote cell proliferation in the presence of p16(INK4a) of hypophosphorylated retinoblastoma family proteins

EMBO Journal

Volumn 16, Issue 17, 1997, Pages 5322-5333

  Alevizopoulos, Konstantinos ^a   Vlach, Jaromir ^a   Hennecke, Silke ^a   Amati, Bruno ^a  

^a SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

CDK; Cyclin; Myc; p16; Retinoblastoma

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN E; ELONGATION FACTOR 2; MYC PROTEIN; PROTEIN KINASE INHIBITOR; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RAT; RETROVIRUS;

3T3 CELLS; ANIMALS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; MICE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RECOMBINANT PROTEINS; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; RETROVIRIDAE; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

ANIMALIA; RODENTIA; UNIDENTIFIED RETROVIRUS;

EID: 0030822196     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.17.5322     Document Type: Article

References (93)

1. Adams, P.D. and Kaelin, W.G. (1996) The cellular effects of E2F overexpression. Curr. Topics Microbiol. Immunol., 208, 79-93.
2. Alexandrow, M.G., Kawabata, M., Aakre, M. and Moses, H.L. (1995) Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor β1. Proc. Natl Acad. Sci. USA, 92, 3239-3243.
3. Assoian, R.K. (1997) Anchorage-dependent cell cycle progression. J. Cell Biol., 136, 1-4.
4. Beijersbergen, R.L., Hijmans, E.M., Zhu, L. and Bernards, R. (1994) Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J., 13, 4080-4086.
5. Beijersbergen, R.L., Carlee, L., Kerkhoven, R.M. and Bernards, R. (1995) Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev., 9, 1340-1353.
6. Bortner, D.M. and Rosenberg, M.P. (1997) Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell. Biol., 17, 453-459.
7. Botz, J., Zerfass-Thome, K., Spitkovsky, D., Delius, H., Vogt, B., Eilers, M., Hatzigeorgiou, A. and Jansen-Dürr, P. (1996) Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol., 16, 3401-3409.
8. Chen, P.-L., Scully, P., Shew, J.-Y. Wang, J.Y.J. and Lee, W.-H. (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell, 58, 1193-1198.
9. Coats, S., Flanagan, W.M., Nourse, J. and Roberts, J.M. (1996) Requirement of p27(kip1) for restriction point control of the fibroblast cell cycle. Science, 272, 877-880.
10. Cobrinik, D. (1996) Regulatory interactions among E2Fs and cell cycle control proteins. Curr. Topics Microbiol. Immunol., 208, 31-61.
11. DeGregor, J., Kowalik, T. and Nevins, J.R. (1995a) Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol., 15, 4215-4224.
12. DeGregori, J., Leone, G., Ohtani, K., Miron, A. and Nevins, J.R. (1995b) E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev., 9, 2873-2887.
13. Du, W., Vidal, M., Xie, J.E. and Dyson, N. (1996) RBF, a novel RB-related gene that regulates E2F activity and interacts with cyclin E in Drosophila. Genes Dev., 10, 1206-1218.
14. Duronio, R.J. and O'Farrell, P.H. (1995) Developmental control of the G1 to S transition in Drosophila: cyclin E is a limiting downstream target of E2F. Genes Dev., 9, 1456-1468.
15. Duronio, R.J., O'Farrell, P.H., Xie, J.E., Brook, A. and Dyson, N. (1995) The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev., 9, 1445-1455.
16. Duronio, R.J., Brook, A., Dyson, N. and O'Farrel, P.H. (1996) E2F-induced S-phase entry requires cyclin E. Genes Dev., 10, 2505-2513.
17. Eilers, M., Schirm, S. and Bishop, J.M. (1991) The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J., 10, 133-141.
18. Fero, M.L. et al. (1996) A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(kip1)-deficient mice. Cell, 85, 733-744.
19. Field, S.J., Tsai, F.Y., Kuo, F., Zubiaga, A.M., Kaelin, W.G., Livingston, D.M., Orkin, S.H. and Greenberg, M.E. (1996) E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell, 85, 549-561.
20. Galaktionov, K., Chen, X. and Beach, D. (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature, 382, 511-517.
21. Garte, S. (1993) The c-myc oncogene in tumor progression. Crit. Rev. Oncogen., 4, 435-449.
22. Geng, Y., Eaton, E.N., Picon, M., Roberts, J.M., Lundberg, A.S., Gifford, A., Sardet, C. and Weinberg, R.A. (1996) Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene, 12, 1173-1180.
23. Goodrich, D.W. and Lee, W.H. (1992) Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53. Nature, 360, 177-179.
24. Gray-Bablin, J., Zalvide, J., Fox, M.P., Knickerbocker, C.J., DeCaprio, J.A. and Keyomarsi, K. (1996) Cyclin E, a redundant cyclin in breast cancer. Proc. Natl Acad. Sci. USA, 93, 15215-15220.
25. Gu, W., Bhatia, K., Magrath, I., Dang, C. and Dalla-Favera, R. (1994) Binding and suppression of the Myc transcriptional activation domain by p107. Science, 264, 251-254.
26. Guan, K.L., Jenkins, C.W., Li, Y., Nichols, M.A., Wu, X., O'Keefe, C.L., Matera, A.G. and Xiong, Y. (1994) Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8, 2939-2952.
27. Hall, M. and Peters, G. (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res., 68, 67-108.
28. Hamel, P.A., Gill, R.M., Phillips, R.A. and Gallie, B.L. (1992) Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. Oncogene, 7, 693-701.
29. Henriksson, M. and Lüscher, B. (1996) Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68, 109-182.
30. Hermeking, H., Funk, J.O., Reichert, M., Ellwart, J.W. and Eick, D. (1995) Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene, 11, 1409-1415.
31. Herrera, R.E., Sah, V.P., Williams, B.O., Makela, T.P., Weinberg, R.A. and Tyler, J. (1996) Altered cell cycle kinetics, gene expression, and G1 restriction point regulation in Rb-deficient fibroblasts. Mol. Cell. Biol., 16, 2402-2407.
32. Hinds, P.W., Mittnacht, S., Dulic, V., Arnold, A., Reed, S.I. and Weinberg, R.A. (1992) Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell, 70, 993-1006.
33. Hirai, H., Roussel, M.F., Kato, J.Y., Ashmun, R.A. and Sherr, C.J. (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15, 2672-2681.
34. Hoang, A.T., Lutterbach, B., Lewis, B.C. Yano, T., Chou, T.Y., Barrett., J.F., Raffeld, M., Hann, S.R. and Dang, C.V. (1995) A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol., 15, 4031-4042.
35. Hofmann, F. and Livingston, D.M. (1996) Differential effects of cdk2 and cdk3 on the control of pRb and E2Ff function during G(1) exit. Genes Dev., 10, 851-861.
36. Jansen-Dürr, P. Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wessbecher, J., Draetta, G. and Eilers, M. (1993) Differential modulation of cyclin gene expression by MYC. Proc. Natl Acad. Sci. USA, 90, 3685-3689.
37. Johnson, D.G., Schwartz, J.K., Cress, W.D. and Nevins, J.R. (1993) Expression of transcription factor E2F-1 induces quiescent cells to enter S phase. Nature, 365, 349-352.
38. Karn, J., Watson, J.V., Lowe, A.D., Green, S.M. and Vedeckis, W. (1989) Regulation of cell cycle duration by c-myc levels. Oncogene, 4, 773-787.
39. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H.J. and Pardee, A.B. (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54, 380-385.
40. Kiyokawa, H. et al. (1996) Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(kip1). Cell. 85, 721-732.
41. Knoblich, J.A., Sauer, K., Jones, L., Richardson, H., Saint, R. and Lehner, C.F. (1994) Cyclin E controls S phase progression and its downregulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell, 77, 107-120.
42. Koh, J., Enders, G.H., Dynlacht, B.D. and Harlow, E. (1995) Tumour-derived p 16 alleles encoding proteins defective in cell-cycle inhibition. Nature, 375, 506-510.
43. Krek, W., Ewen, M.E., Shirodkar, S., Arany, Z., Kaelin, W.J. and Livingston, D.M. (1994) Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell. 78, 161-172.
44. Krude, T., Jackman, M., Pines, J. and Laskey, R.A. (1997) Cyclin/Cdk-dependent initiation of DNA replication in a human cell-free system. Cell, 88, 109-119.
45. Lam, E.W. and Watson, R.J. (1993) An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J., 12, 2705-2713.
46. Land, H., Parada, L.F. and Weinberg, R.A. (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 304, 596-602.
47. Lees, E., Faha, B., Dulic, V., Reed, S.I. and Harlow, E. (1992) Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev., 6, 1874-1885.
48. Lukas, J., Muller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A.A., Jansen-Durr, P., Strauss, M. and Bartek, J. (1994) DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin Dl function in G1. J. Cell Biol., 125, 625-638.
49. Lukas, J., Bartkova, J., Rohde, M., Strauss, M. and Bartek, J. (1995a) Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol., 15, 2600-2611.
50. Lukas, J., Parry, D., Aagaard, L., Mann, D.J., Bartkova, J., Strauss, M., Peters, G. and Bartek, J. (1995b) Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature, 375, 503-506.
51. Lukas, J., Otzen Petersen, B., Holm, K., Bartek, J. and Helin, K. (1996) Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol. Cell. Biol., 16, 1047-1057.
52. Mann, D.J. and Jones, N.C. (1996) E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Curr. Biol., 6, 474-483.
53. Marcu, K.B., Bossone, S.A. and Patel, A.J. (1992) myc function and regulation. Annu. Rev. Biochem., 61, 809-860.
54. Medema, R.H., Herrera, R.E., Lam, F. and Weinberg, R.A. (1995) Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl Acad. Sci. USA, 92, 6289-6293.
55. Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134.
56. Morgenstern, J.P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18, 3587-3596.
57. Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Hori, I., Loh, D.Y. and Nakayama, K. (1996) Mice lacking p27(kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85, 707-720.
58. Nevins, J.R. (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science, 258, 424-429.
59. Ohtani, K., DeGregori, J. and Nevins, J.R. (1995) Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl Acad. Sci. USA, 92, 12146-12150.
60. Ohtsubo, M. and Roberts, J.M. (1993) Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science, 259, 1908-1912.
61. Ohtsubo, M., Theodoras, A.M., Schumacher, J., Roberts, J.M. and Pagano, M. (1995) Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol., 15, 2612-2624.
62. Perez-Roger, I., Solomon, D.L.C., Sewing, A. and Land, H. (1997) Myc activation of cyclin E/CDK2 kinase involves induction of cyclin E gene transcription and inhibition of p27Kip1 binding to newly formed complexes. Oncogene, 14, 2373-2381.
63. Polyak, K., Lee, M.H., Erdjumem, B.H., Koff, A., Roberts, J.M., Tempst, P. and Massague, J. (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
64. Porter, P.L., Malone, K.E., Heagerty, P.J., Alexander, G.M., Gatti, L.A., Firpo, E.J., Daling, J.R. and Roberts, J.M. (1997) Expression of cell-cycle regulators p27(kip1) and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med 3, 222-225.
65. Pusch, O., Bernaschek, G., Eilers, M. and Hengstschlager, M. (1997a) Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene, 15, 649-656.
66. Pusch, O., Soucek, T., Hengstschlager-Ottnad, E., Bernaschek, G. and Hengstschläger, M. (1997b) Cellular targets for activation by c-Myc include the DNA metabolism enzyme thymidine kinase. DNA Cell Biol., 16, 737-747.
67. Qin, X.-Q., Livingston, D.M., Kaelin, W.G. and Adams, P.D. (1994) Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl Acad. Sci. USA, 91, 10918-10922.
68. Qin, X.-Q., Livingston, D.M., Ewen, M., Sellers, W.R., Arany, Z. and Kaelin, W.G. (1995) The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol., 15, 742-755.
69. Quelle, D.E. et al. (1995) Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene, 11, 635-645.
70. Resnitzky, D. and Reed, S.I. (1995) Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell. Biol., 15, 3463-3469.
71. Schwarz, J.K., Devoto, S.H., Smith, E.J., Cheliappan, S.P. Jakoi, L. and Nevins, J.R. (1993) Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J., 12, 1013-1020.
72. Serrano, M., Lee, H., Chin, L., Cordon, C.C., Beach, D. and DePinho, R.A. (1996) Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85, 27-37.
73. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D. and Lowe, S.W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 88, 593-602.
74. Shan, B. and Lee, H.-W. (1994) Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol., 14, 8166-8173.
75. Sherr, C.J. (1994) G1 phase progression: cycling on cue. Cell, 79, 551-555.
76. Sherr, C.J. (1995) D-type cyclins. Trends Biochem. Sci., 20, 187-190.
77. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
78. Soucek, T., Pusch, O., Hengstschlager-Ottnad, E., Adams, P.D. and Hengstschläger, M. (1997) Deregulated expression of E2F-1 induces cyclin A- and E-associated kinase activities independently from cell cycle position. Oncogene, 14, 2251-2257.
79. 1 cyclin-cdk complexes. EMBO J., 14, 4814-4826.
80. Stillman, B. (1996) Cell cycle control of DNA replication. Science, 274, 1659-1664.
81. Strausfeld, U.P., Howell, M., Rempel, R., Maller, J.L., Hunt, T. and Blow, J.J. (1994) CIP1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases. Curr. Biol., 4, 876-883.
82. Templeton, D.J., Park, S.H., Lanier, L. and Weinberg, R.A. (1991) Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl Acad. Sci. USA, 88, 3033-3037.
83. Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
84. Vairo, G., Livingston, D.M. and Ginsberg, D. (1995) Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev., 9, 869-881.
85. Kip1 is abrogated by c-Myc. EMBO J., 15, 6595-6604.
86. Wang, J.Y.J. (1997) Retinoblastoma protein in growth suppression and death protection. Curr. Opin. Genet. Dev., 1, 39-45.
87. Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323-330.
88. Weinberg, R.A. (1996) E2F and cell proliferation: a world turned upside down. Cell, 85, 457-459.
89. Wu, C.L., Classon, M., Dyson, N. and Harlow, E. (1996) Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1. Mol. Cell. Biol., 16, 3698-3706.
90. Yamasaki, L., Jacks, J., Bronson, R., Goillot, E., Harlow, E. and Dyson, N.J. (1996) Tumor induction and tissue atrophy in mice lacking E2F-1. Cell, 85, 537-548.
91. Zerass-Thome, K., Schulze, A., Zwerschke, W., Vogt, B., Helm, K., Bartek, M., Henglein, B. and Jansen-Dürr, P. (1997) P27(kip1) blocks cyclin E-dependent transactivation of cyclin a gene expression. Mol. Cell. Biol., 17, 407-415.
92. Zhu, L., van den Heuvel, S., Helin, K., Fallacy, A., Ewen, M., Livingston, D.M., Dyson, N. and Harlow, E. (1993) Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 1, 1111-1125.
93. Zwicker, J. and Müller, R. (1997) Cell-cycle regulation of gene expression by transcriptional repression. Trends Genet., 13, 3-6.